INTRODUCTION {#sec1-1}
============

Malaria is a deadly parasitic disease\[[@ref1]\] and causes 2 million deaths annually worldwide.\[[@ref2]\] The biggest problem in its eradication is the growing resistance of *Plasmodium falciparum*, which may cause the most fatal form of malaria,\[[@ref3]\] to almost all of the currently available malarial drugs.\[[@ref4]\] Even with the current multidrug therapy program, *P. falciparum* has developed drug resistance against the latest antiplasmodial drug from the artemisinin family.\[[@ref5]\] Although malaria drug resistance is also affected by several socioeconomic factors, a new antiplasmodial agent is needed for a global malaria control program.

From the hundreds of compounds tested for their antiplasmodial activities, plants and other natural compound are among the most promising.\[[@ref6][@ref7][@ref8]\] Quinine, the first antimalarial agent, and the next generation of antimalarial agents, including lapachol and artemisinin, have been isolated from plants.\[[@ref9][@ref10]\] We previously reported the antiplasmodial activity of kaempferol-3-*O*-rhamnoside isolated from *Schima wallichii* leaves against chloroquine-resistant *P. falciparum*.\[[@ref11]\] Furthermore, our group also reported the antiplasmodial potential of several selenium compounds to induce apoptosis-like cell death in *P. falciparum*.\[[@ref12]\]

One of the approaches to find a novel drug from plants is using plants that are consumed by particular groups.\[[@ref13]\] In recent years, we focused our research on discovering bioactive compounds from plants commonly consumed by nonhuman primates, as they are considered to be a promising source of products applicable for the management of human disease.\[[@ref14]\] In the present study, we focused on the exploration of the antiplasmodial activities of *Garcinia celebica* leaves, one of the plants that is consumed by nonhuman primates with anticancer potential.\[[@ref15]\] In our previous studies, we reported the anticancer potential of kaempferol-3-*O*-rhamnoside,\[[@ref16][@ref17]\] a compound that is isolated from the nonhuman primate-consumed plant *S. wallichii*, which also has antiplasmodial properties.\[[@ref11]\] Thus, in the present study, the antiplasmodial properties of *G. celebica* leaves were investigated, and their active compound was identified.

MATERIALS AND METHODS {#sec1-2}
=====================

Plant materials {#sec2-1}
---------------

*G. celebica* leaves were collected from Pangandaran Beach conservation area in West Java Province of Indonesia. The leaf of *G. celebica* was identified, and specimen also deposited in the Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Bandung, Indonesia.

Extract and fraction preparation {#sec2-2}
--------------------------------

The powdered *G. celebica* leaves were extracted with 95% ethanol (3 times each for 24 h) at room temperature, and the solvent was evaporated under reduced pressure at 50°C to yield concentrated extracts. The extracts were further fractionated based on their polarity in a mixture of *n*-hexane-water (1:1) to produce hexane and water layers, and the water layer was further extracted with ethyl acetate to yield the ethyl acetate and water fractions. The crude extract, *n*-hexane, ethyl acetate, and water fractions were tested for their antiplasmodial properties against chloroquine-resistant *P. falciparum*.

Isolation and identification of the active compound {#sec2-3}
---------------------------------------------------

The ethyl acetate fraction, which was the most active fraction, was chromatographed on Wakogel C-200 (Wako Pure Chemical, Japan) with a mixture of *n*-hexane, ethyl acetate, and methanol with increased polarity. The active compound, for which the isolation was guided by Brine Shrimp Lethality Test,\[[@ref18]\] was purified using silica G-60 with sulfuric acid-ethanol (1:9) and identified by spectroscopy methods including ultraviolet and infrared spectrometry (UV-IR), nuclear magnetic resonance (NMR), and liquid chromatography--mass spectrometry (LC-MS).\[[@ref19]\]

*Plasmodium falciparum* culture condition {#sec2-4}
-----------------------------------------

Chloroquine-resistant *P. falciparum* strain DD2 was grown asynchronously as described previously,\[[@ref20]\] in disposable culture dishes (Greiner, Frickenhausen, Germany) under a controlled atmosphere of 5% CO~2~ and 5% O~2~ at 37°C. The parasite was grown in RPMI-1640 medium (Sigma-Aldrich, St Louis, MO, USA) containing 10% type B or O human serum (the serum type showed no significant difference to parasite growth), 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Wako, Osaka, Japan), 25 μg/ml gentamycin (Sigma-Aldrich, St. Louis, MO, USA), 25 mM sodium bicarbonate (Wako, Osaka, Japan), and human type O red blood cells (RBCs) to make a final 5% hematocrit mixture.

Growth inhibitory effect of *Garcinia celebica* against *Plasmodium falciparum* {#sec2-5}
-------------------------------------------------------------------------------

The growth inhibitory effect of crude extract, ethyl acetate fraction, *n*-hexane fraction, and water fraction of *G. celebica* leaves was assessed by exposing *P. falciparum* to a medium containing 100 μg/ml of each extract and fraction. The growth inhibitory effect of the active compound isolated from the ethyl acetate fraction of *G. celebica* leaves was assessed in a medium containing 345 μM of the compound. An unsynchronized parasite culture with an initial parasitemia of 0.1% was used. The culture medium containing the extract was changed, and the number of parasitized RBCs (pRBCs) was counted every 24 h. The pRBCs were counted by making Giemsa-stained thin-smeared slides, and the number of pRBCs in 3000 RBCs was determined under a light microscope at 1000 times magnification. This experiment was terminated at 72 h. Each of the extracts was assessed in triplicate. Dimethyl sulfoxide was added to the culture medium to make a 0.0003% final concentration mixture as the untreated control.

Concentration-dependent antiplasmodial effect of the active compound {#sec2-6}
--------------------------------------------------------------------

The pRBCs were synchronized by introducing 5% D-sorbitol into the culture for 15 min as reported elsewhere,\[[@ref20]\] and they were washed three times using RPMI and reintroduced into a similar culture condition as stated in the previous section of this report. This step was repeated after 12 h to produce a tightly synchronized culture. The parasite cultures at 2% parasitemia were moved into 24-well culture plates, and the culture solution containing the active compound of the ethyl acetate fraction of *G. celebica* leaves at concentrations of 0 (control), 34.5, 172.5, and 345 μM. The culture was incubated for 24 h at 37°C and then checked for growth. Once the majority of the parasites in the control well were formed into schizont, the plates were removed from the incubator, and thin-smeared Giemsa slides were made from each well. We counted the RBCs in the control well until we found fifty schizonts. The concentration-dependent antiplasmodial effects were evaluated by comparing the number of schizonts found in the same number of RBCs as counted from the control wells. This procedure was performed three times, and then the inhibition curve was made, and the IC~50~ was determined from the inhibition curve.

Stage-specific antiplasmodial effect {#sec2-7}
------------------------------------

The stage-specific antiplasmodial effect of the active compound at its IC~50~ concentration was evaluated with chloroquine diphosphate (CQ) used as a positive control. In brief, the pRBCs were tightly synchronized as described above, and the active compound was introduced into the culture. After 24 h, thin-smeared Giemsa slides were made, and the number of pRBCs in 3000 RBCs was determined under a light microscope at 1000 times of magnification. CQ (Wako, Osaka, Japan) diluted in milli-Q water was used as a positive control at its IC~50~ concentration of 370 nM. Each treatment group was made in triplicate, and the experiment was performed three times.

Influence of ascorbic acid on the antiplasmodial effect of active compounds {#sec2-8}
---------------------------------------------------------------------------

Parasites at 2% parasitemia were prepared in 24-well culture plates containing either 0, 250, or 500 μM of ascorbic acid (Wako, Osaka, Japan) and treated with the active compounds at its IC~50~ concentration. The culture plates were incubated at 37°C for 24 h before the thin-smeared Giemsa slides were made for each well. The number of pRBCs in 3000 RBCs was determined under a light microscope at 1000 times of magnification. Each treatment group was made in triplicate, and the experiment was performed three times.

Statistical analysis {#sec2-9}
--------------------

Statistically significant differences were determined by Student\'s *t*-test. *P* \< 0.05 was considered a statistically significant difference.

RESULTS {#sec1-3}
=======

Ethyl acetate fractions of *Garcinia celebica* leaves inhibit *Plasmodium falciparum* growth {#sec2-10}
--------------------------------------------------------------------------------------------

Treatment with the *G. celebica* extract at the concentration of 100 μg/ml inhibited *P. falciparum* growth \[[Figure 1](#F2){ref-type="fig"}\]. The extract was then fractionated based on polarity and using *n*-hexane, ethyl acetate, and water. The fractions were then individually applied to a *P. falciparum* culture at a concentration of 100 μg/ml each \[[Figure 1](#F2){ref-type="fig"}\] and were found to inhibit *P. falciparum* growth. Due to its strong inhibition of *P. falciparum* growth, we then explored the ethyl acetate fraction for further antiplasmodial potential.

![*Garcinia celebica* leaf extract and fractions inhibit *Plasmodium falciparum* growth](PM-13-301-g002){#F2}

Catechin is the active compound of the ethyl acetate fraction of *Garcinia celebica* leaves {#sec2-11}
-------------------------------------------------------------------------------------------

Catechin was isolated from the leaves of *G. celebica* as a white yellowish crystalline solid. It had a molecular ion peak at m/z 290 in the EI mass spectrum, which indicated that this compound had a molecular formula of C~15~H~14~O~6~. This compound showed absorption bands at 220 and 275 nm (MeOH) in the UV spectrum, which indicated the possibility of the compound belonging to a flavan compound of the flavonoid group,\[[@ref21]\] and the IR spectrum has a broadband of approximately 3500--2800 cm^−1^ region corresponding to aliphatic and aromatic C-H and phenolic and alcoholic O-H stretching. A band appearing at 1600 cm^−1^ may be derived from aromatic C = C stretching, and no band of the carbonyl group was observed. The UV and IR characteristics suggested that the compound may be a flavan-3-ol derivative of the flavonoid group.\[[@ref21]\]

As seen in [Figure 2](#F3){ref-type="fig"}, the ^1^H NMR spectrum of this compound showed signals at δ 2.73 (1H, *dd*, *J* = 2.6 and 16.9 Hz), 2.8 (1H, *dd*, *J* = 4.5 and 16.9 Hz), 4.18 (1H, *m*), and 4.82 (1H, *br s*), which are characteristic of the --CH2-CH-CH-O group of the flavanol skeleton.\[[@ref21]\] Furthermore, the ^1^H NMR spectrum revealed two signals at δ 5.91 (1H, *d*, *J* = 2.0 Hz) and δ 5.94 (1H, *d*, *J* = 2.0 Hz), which are attributed to two aromatic hydrogens of the A benzene ring and three signals at δ 6.75 (1H, *d*, *J* = 8.5 Hz), δ 6.80 (1H, *dd*, *J* = 2.0 and 8.5 Hz), and δ 6.97 (1H, *d*, *J* = 2.0 Hz), which were derived from those of the B benzene ring, with each of the rings termed the A- and B-rings on the left and right of the flavanol skeleton, respectively. The above data suggest that this compound is catechin.

![The ^1^H NMR profile of catechin obtained from the leaves of *Garcinia celebica*](PM-13-301-g003){#F3}

The ^13^C NMR spectrum identified the presence of 15 carbons derived from 12 aromatic carbons appearing at δ 96.0, 96.5, 100.2, 115.4, 116.0, 119.5, 132.4, 145.9, 146.0, 157.8, 157.8, and 158.1 and three other carbons at δ 29.4, 67.6, and 80.0. The ^1^H and ^13^C NMR data suggested that the compound was catechin \[[Figure 3](#F4){ref-type="fig"}\], which was confirmed by comparison of its spectral data with those of reported (+)-catechin.\[[@ref21]\]

![The structure of (+)-catechin](PM-13-301-g004){#F4}

Catechin inhibit *Plasmodium falciparum* growth in a time- and dose-dependent manner {#sec2-12}
------------------------------------------------------------------------------------

The antiplasmodial effect of catechin was observed in *P. falciparum* culture at the concentration of 345 μM and for 72 h. The results shown in [Figure 4a](#F5){ref-type="fig"} indicate that the antiplasmodial properties of catechin were dose dependent. Subsequent analysis of the antiplasmodial activities against a *P. falciparum* culture using various concentrations (0, 34.5, 172, and 345 μM) of catechin for 24 h showed that the IC~50~ value of catechin was 198 μM \[[Figure 4b](#F5){ref-type="fig"}\].

![Catechin inhibits *Plasmodium falciparum* growth in a (a) time- and (b) dose-dependent manner](PM-13-301-g005){#F5}

Catechin inhibits *Plasmodium falciparum* growth in both trophozoite and schizont stages {#sec2-13}
----------------------------------------------------------------------------------------

As seen in [Figure 5](#F6){ref-type="fig"}, the results of the stage-specific antiplasmodial experiment show that catechin at its IC~50~ concentration inhibited *P. falciparum* growth in both trophozoite and schizont developmental stages.

![Catechin inhibits *Plasmodium falciparum* growth in both the trophozoite and schizont stages. \**Plasmodium falciparum* growth is significantly different compared to the control (*P* \< 0.05)](PM-13-301-g006){#F6}

Ascorbic acid decreased the antiplasmodial properties of catechin against *Plasmodium falciparum* {#sec2-14}
-------------------------------------------------------------------------------------------------

Oxidative stress has been reported to play a major role in several antiplasmodial compounds.\[[@ref22][@ref23][@ref24]\] As seen in [Figure 6](#F7){ref-type="fig"}, the addition of ascorbic acid in a dose-dependent manner gradually decreased the antiplasmodial activity of catechin against *P. falciparum*.

![Ascorbic acid decreased the antiplasmodial properties of catechin](PM-13-301-g007){#F7}

DISCUSSION {#sec1-4}
==========

With the high prevalence of malaria cases, especially in tropical countries, the search for naturally occurring agents that may inhibit malaria parasite development is becoming an important objective for scientists. This study shows that *G. celebica* leaves, which were previously reported for their anticancer properties, possessed antiplasmodial properties against chloroquine-resistant *P. falciparum*. This result is similar to previous findings of nonhuman primate consumption of *S. wallichii* leaves\[[@ref11]\] and a traditional West African medicinal plant, *Cryptolepis sanguinolenta* (Lindl.) Schltr (Periplocaceae),\[[@ref25]\] which were both reported to possess anticancer and antimalarial properties.

*G. celebica*, also known as seashore mangosteen, is a medium-sized tree that can grow up to 30 m tall and has spread from Southeast Asia to Papua New Guinea in the east and eastern India to the west. It can be found in lowland forest near the sea and is also distributed in the inland forest up to 1200 m of altitude.\[[@ref26]\] In some areas, the trees are commercially and culturally planted for ornamental purposes, and its fruits, roots, and leaves are also ethnobotanically used for the treatment of itchiness and made into decoction for women after childbirth.\[[@ref27]\]

In this study, the ethyl acetate fraction of the *G. celebica* leaves extract showed antiplasmodial activities against *P. falciparum* culture, and it was as strong as those of the crude extract \[[Figure 1](#F2){ref-type="fig"}\]. This suggests that the compound responsible for the antiplasmodial properties of *G. celebica* leaves may be contained in the ethyl acetate fraction. Therefore, we then explored this ethyl acetate fraction for its antiplasmodial potential.

From the ethyl acetate fraction of *G. celebica* leaves and guided by Brine Shrimp Lethality Test as a simple biological test to guide pharmacologic activities,\[[@ref18]\] we isolated catechin as the active compound. Catechin is a flavonoid widely reported for its anticancer potential.\[[@ref28][@ref29][@ref30]\] It has also been reported to reduce atherosclerotic lesions in a mouse model.\[[@ref31]\] Our results suggested that catechin also inhibits chloroquine-resistant *P. falciparum* growth in a time- and dose-dependent manner \[[Figure 4](#F5){ref-type="fig"}\], with an IC~50~ concentration of 198 μM against chloroquine-resistant *P. falciparum* in a 24 h treatment.

This study also suggested that the treatment of catechin significantly reduced parasitemia in both blood stages of *P. falciparum*, trophozoites and schizont, from the initial parasite generation \[[Figure 5](#F6){ref-type="fig"}\]. The inhibition of *P. falciparum* growth in the trophozoites stage will inhibit their development to the schizont stage,\[[@ref32]\] whereas inhibition of the schizont stage will inhibit their rupture, which will release merozoites.\[[@ref33]\] These blood stages are responsible for the sequestration of *P. falciparum* that results in the major pathology of severe malaria, which is characterized by a fever cycle that embodies the clinical manifestations of malaria.\[[@ref33]\] Thus, the ability of catechin to inhibit both of the blood stages increases the probability of developing a new antimalarial compound that is effective in clearing the blood from merozoites and also prohibits the occurrence of rosette or severe forms of malaria.

*Plasmodium* is highly susceptible to oxidative stress. Therefore, elevation of oxidative stress as a result of inhibition of any component of their oxidative stress and antioxidant defense system will lead to a redox imbalance.\[[@ref34]\] The redox system plays important roles for the survival of *Plasmodium* within the host and disturbing the redox balance will affect the survival of *Plasmodium* during intraerythrocytic stages.\[[@ref35]\] Furthermore, Goyal also suggested that identification of compounds that can disrupt the *Plasmodium* redox balance and consequently promote oxidative stress will be an effective approach in the development of novel antimalarial drugs.\[[@ref34]\] Interestingly, in this study, the addition of ascorbic acid as an antioxidant agent against the *P. falciparum* culture subsequently decreased the inhibition of catechin to *P. falciparum* growth. This suggests that the antiplasmodial properties of catechin against *P. falciparum* occur through the induction of oxidative stress.

CONCLUSION {#sec1-5}
==========

This study provides more evidence that products derived from plants hold potential in the treatment and prevention of human diseases. Thus, it is important to explore the pharmacological activities of plants and their active isolated compounds, including their exact mechanisms to provide valuable evidence for their possible application in human disease therapy and prevention. Although this is a preliminary study, the findings provide a basis for subsequent investigations of catechin as a potential compound for antimalarial drug development.
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